Yousif Capital Management LLC lowered its position in shares of Relx Plc (NYSE:RELX – Free Report) by 15.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,961 shares of the technology company’s stock after selling 4,000 shares during the quarter. Yousif Capital Management LLC’s holdings in Relx were worth $997,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. CENTRAL TRUST Co raised its position in shares of Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in Relx in the fourth quarter valued at about $31,000. Private Trust Co. NA increased its holdings in Relx by 119.9% in the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after purchasing an additional 566 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Relx in the third quarter valued at about $125,000. Finally, Whittier Trust Co. of Nevada Inc. grew its stake in Relx by 33.9% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 3,952 shares of the technology company’s stock valued at $188,000 after acquiring an additional 1,000 shares during the period. Institutional investors own 15.02% of the company’s stock.
Relx Stock Down 1.5 %
NYSE:RELX opened at $51.14 on Friday. Relx Plc has a 1 year low of $40.25 and a 1 year high of $51.99. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.48 and a quick ratio of 0.42. The stock has a 50-day moving average price of $47.74 and a two-hundred day moving average price of $47.13.
Analyst Upgrades and Downgrades
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- Trading Stocks: RSI and Why it’s Useful
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Ride Out The Recession With These Dividend Kings
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Differences Between Momentum Investing and Long Term Investing
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.